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warranted, particularly where utilization rates exceed
DVT incidence.
Table.
Procedure category
Primary
cases
(N)
Secondary VCF
utilization rate
(per 1000 cases)
DVT rate
(per 1000
cases)
Bariatric 69,814 2.49 1.58
Colon 108,898 0.38 7.77
Hepatobiliary 87,454 0.16 2.24
Peripheral vascular 22,445 0.62 7.31
Gastric (non-bariatric) 7,972 1.63 7.65
Amputation 6,312 1.58 8.40
Abdominal exploratory 7,811 1.28 13.95
Aortic 7,173 1.25 9.34
Hernia repair 51,520 0.16 1.98
Skin/soft tissue 3,463 2.30 4.90
Endocrine 2,019 3.47 2.97
Esophageal 13,143 0.46 5.25
Small bowel 14,454 0.42 12.94
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Objectives: The post thrombotic syndrome (PTS) is a
chronic condition that develops in 20% to 50% of patients
after deep venous thrombosis (DVT). It is characterized by
chronic pain, swelling and heaviness, and may result in
ulceration. Elastic compression stockings (ECS) worn daily
after DVT have been shown to reduce the incidence and
severity of PTS. The aim of our study was to investigate
practices and perceptions of physicians regarding adjunct
therapies to anticoagulation in patients diagnosed with
lover extremity DVT.
Methods: An online survey was conducted of Cana-
dian primary care staff physicians and residents (n685) to
investigate their attitudes towards prescription of ECS post
diagnosis of DVT.
Results: The results demonstrated that the majority of
staff physicians (58%) and residents (58%) were unsure
whether ECS were effective in preventing PTS and in
managing venous symptoms. This resulted in only 12% of
staff physicians and 26% of residents routinely prescribing
ECS for below-knee DVTs. Only 10% of staff physicians
and 12% of residents routinely prescribed ECS for above-
knee DVTs. More than 70% of respondents were unsure
about the optimal timing of initiation of ECS and duration
of therapy. A majority of staff and resident respondents
correctly predicted two out of the top three reasons for
patient non-compliance (soreness and the need for assis-
tance, but not cosmesis).
Conclusions: Daily use of graduated ECS after DVT
appears to reduce the risk of PTS. Our results demonstrate
that there is a lack of consensus among medics regarding
ECS use after DVT. There is a need for widespread educa-
tion regarding the latest evidence of the benefit of ECS
after DVT.
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Objectives: Current Chest guidelines counsel at least 3
months of anticoagulation (AC) to treat UEDVTs, yet are
not consistently followed among fragile patients. We
sought to correlate AC use with DVT characteristics and
patient outcomes.
Methods: Four hundred consecutive UEDVT patients
were identified between 2005 and 2009 from our Vascular
Lab Registry. Sonographic and patient characteristics, AC
treatment, PE incidence, mortality and hemorrhagic com-
plications were reviewed.
Results: Among the 400 patients, UEDVT was docu-
mented in the distal innominate (n91), internal jugular
(n 192), subclavian (n 211), axillary (n 146), and
brachial veins (n125). Most were symptomatic (n350,
88%), with sonographically acute appearance (n335,
84%). Many patients had documented malignancy
(n153, 38%), or associated central venous lines (n323,
81%), and most were treated with heparin and/or warfarin.
(n207, 52%). Thirteen patients (3%) suffered PE in asso-
ciation with their UEDVT diagnosis. There was no PE-
related mortality. Following discharge, 4 patients treated
with warfarin died from intracranial hemorrhage. Five ad-
ditional patients required hospital readmission for AC-
related intracranial, GI, and stomal hemorrhage.
Conclusions:AC ismost commonly used to treat more
extensive acute DVT components in younger patients with
better short-term survival. The incidence of PE does not
appear to be improved by AC treatment. Given the ob-
served morbidity and mortality associated with AC, and the
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small risk of PE, the practice of more limited and selective
AC to treat UEDVT seems warranted.
Table. Comparison of patient andUEDVT characteristics
among anticoagulated and nonanticoagulated patients
Patient/DVT characteristic AC () AC (-) P value
Patient age 48/-18 54/-17 .002a
Death at 3 months 26/107 (13%) 51/193 (26%) .001b
UEDVT associated PE 11/207 (5%) 2/193 (1%) .02b
# named DVT segments 2.1/-1.2 1.7/-1.0 .001b
Acute DVT component 185/207 (89%) 148/193 (77%) .001b
at-test;
bChi-square
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Objectives: Early postoperative ambulation prevents
deep vein thrombosis (DVT) by enhancing lower extremity
(LE) venous flow. Postoperative patients may require pro-
longed bed-rest. We tested if upper body exercise (UBE)
increased LE venous flow, as a potential means for prevent-
ing DVT.
Methods: 15 healthy volunteers (20-40 yrs) performed
4 low-intensity (5watts, 75rpm) UBE protocols on an
ergometer (single 30-sec and 3-min UBE bouts; and 3
repetitions of 30-sec and 3-min bouts with 1 min rest
between bouts). External iliac vein volume flow was mea-
sured by ultrasound before and after UBE.
Results: A single 30-sec bout of UBE increased LE
volume flow by 39%; the increase was maintained up to 10
mins post-exercise (P .05). A single 3-min bout of UBE
increased flow by 23% (P  .05); flow was elevated (19%)
for 5 mins (P .07). With 3 repetitions of the 30-sec UBE
bouts, flow increased 57% after 1 bout and remained34%
higher after the remaining bouts for a total of 8.5 min of
increased venous flow (P .05, Fig). With repeated 3-min
UBE, flow increased 32% after 1 bout, and remained21%
higher after the remaining bouts for an additional 5 mins
(P .05).
Conclusions: We report a novel finding that UBE
increases LE venous blood flow. The effect is consistent and
durable. Three 30-sec bouts of low-intensity UBE was the
most effective; eliciting a net increase of 4.5L of LE
venous flow over8.5 minutes. UBEmay be an alternative
for prophylaxis of DVT in patients with restricted ambula-
tion.
Venous volume flow in the lower extremity after upper
body exercise (3 bouts of 30-seconds ergometry).
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Objectives: Instruments to evaluate outcomes post VV
treatments mix symptoms/signs and health-related quality
of life. In contrast, the VV Symptoms Questionnaire
(VVSymQ™), a patient-reported outcome instrument de-
veloped using iterative qualitative interviews with patients,
considers only symptoms. To evaluate feasibility, reliability
and validity of the VVSymQ™ via a PDA for measure of VV
symptoms before and after great saphenous vein (GSV)
closure (immediately preceding wk 8 visit) and to estimate
treatment effect size (ES), the VVSymQ™ was adminis-
tered daily using a PDA 14 days pre  10 days post GSV
closure.
Methods: VVSymQ™ assessed duration and intensity
(6 and 11 point scales) of the 5 most important VV symp-
toms. Feasibility was evaluated by compliance; reliability by
agreement between 1st and 2nd 7-day pre-GSV closure
scores; and validity by correlation with other instruments:
PA-VA3, VCSS, VEINES QoL, CIVIQ-20.
Fig.
JOURNAL OF VASCULAR SURGERY
June Supplement 201264S Abstracts
